Difficulty: Medium
Average Score: 87%
Practice
This drug is useful in terminating atrial but not ventricular tachycardias:
Correct answer
D
Rationale
In the context of safety pharmacology across the lifespan, understanding the mechanisms of action of antiarrhythmic drugs is crucial. In this scenario, the correct answer is D) Verapamil.
Verapamil is a calcium channel blocker that primarily affects the AV node, making it effective in terminating atrial tachycardias by slowing conduction through the AV node. It is not as effective in terminating ventricular tachycardias because these rhythms are often driven by mechanisms that do not involve the AV node.
A) Flecainide is a sodium channel blocker that is more effective in ventricular tachycardias rather than atrial tachycardias.
B) Sotalol is a non-selective beta-blocker with Class III antiarrhythmic properties, effective in both atrial and ventricular tachycardias.
C) Lidocaine is a sodium channel blocker primarily used for ventricular arrhythmias, not atrial tachycardias.
Understanding the specific mechanisms of action of antiarrhythmic drugs is essential for healthcare professionals across the lifespan to make informed decisions in managing cardiac arrhythmias, ensuring patient safety and optimal outcomes.
Verapamil is a calcium channel blocker that primarily affects the AV node, making it effective in terminating atrial tachycardias by slowing conduction through the AV node. It is not as effective in terminating ventricular tachycardias because these rhythms are often driven by mechanisms that do not involve the AV node.
A) Flecainide is a sodium channel blocker that is more effective in ventricular tachycardias rather than atrial tachycardias.
B) Sotalol is a non-selective beta-blocker with Class III antiarrhythmic properties, effective in both atrial and ventricular tachycardias.
C) Lidocaine is a sodium channel blocker primarily used for ventricular arrhythmias, not atrial tachycardias.
Understanding the specific mechanisms of action of antiarrhythmic drugs is essential for healthcare professionals across the lifespan to make informed decisions in managing cardiac arrhythmias, ensuring patient safety and optimal outcomes.